Immix Biopharma, Inc. (IMMX) stock
IMMXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$7.20−0.28 (-3.74%)
Close on Nov 17, 2026Market cap $515.08MP/E –Yield –
Immix Biopharma total assets
Total assets on the balance sheet at the end of each period.
Immix Biopharma's total assets was $239.11M at Jun 30, 2026. For fiscal 2025 it was $104.84M, up 356.9% from the year before. The highest annual figure on record is $104.84M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $104.84M | +356.9% |
| FY2024 | Dec 31, 2024 | $22.95M | +15.2% |
| FY2023 | Dec 31, 2023 | $19.93M | +33.7% |
| FY2022 | Dec 31, 2022 | $14.91M | -18.1% |
| FY2021 | Dec 31, 2021 | $18.19M | +3271.4% |
| FY2020 | Dec 31, 2020 | $539.60K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $239.11M | +1429.3% |
| Q1 FY2026 | Mar 31, 2026 | $95.82M | +381.7% |
| Q4 FY2025 | Dec 31, 2025 | $104.84M | +356.9% |
| Q3 FY2025 | Sep 30, 2025 | $20.08M | -20.1% |
| Q2 FY2025 | Jun 30, 2025 | $15.64M | -45.8% |
| Q1 FY2025 | Mar 31, 2025 | $19.89M | -42.1% |
| Q4 FY2024 | Dec 31, 2024 | $22.95M | +15.2% |
| Q3 FY2024 | Sep 30, 2024 | $25.14M | +11.9% |
| Q2 FY2024 | Jun 30, 2024 | $28.84M | +85.2% |
| Q1 FY2024 | Mar 31, 2024 | $34.35M | +160.0% |
| Q4 FY2023 | Dec 31, 2023 | $19.93M | +33.7% |
| Q3 FY2023 | Sep 30, 2023 | $22.47M | +29.2% |
| Q2 FY2023 | Jun 30, 2023 | $15.57M | -18.4% |
| Q1 FY2023 | Mar 31, 2023 | $13.21M | -34.0% |
| Q4 FY2022 | Dec 31, 2022 | $14.91M | -18.1% |
| Q3 FY2022 | Sep 30, 2022 | $17.40M | +3123.7% |
| Q2 FY2022 | Jun 30, 2022 | $19.09M | – |
| Q1 FY2022 | Mar 31, 2022 | $20.02M | – |
| Q4 FY2021 | Dec 31, 2021 | $18.19M | – |
| Q4 FY2020 | Dec 31, 2020 | $539.60K | – |
See a number that looks wrong?